echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > "Metformin + insulin" vs "metformin + sulfonylureas", who has better hypoglycemic efficacy and cardiovascular outcomes?

    "Metformin + insulin" vs "metformin + sulfonylureas", who has better hypoglycemic efficacy and cardiovascular outcomes?

    • Last Update: 2022-09-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Globally, 463 million people had diabetes in 2019, and this number is expected to reach 578 million by 2030 and 700 million


    The American Diabetes Association recommends lifestyle changes as the first step


    Metformin and sulfonylureas are the most commonly used combination therapies


    The Current Standard of Care of the American Diabetes Association recommends that 8.


    The researchers conducted a comparative cross-sectional study


    Of all the participants selected, 50.


    Two-factor and multivariate Logistic regression analysis of factors associated with target levels of glycosylated hemoglobin in patients with diabetes mellitus

    The risk of combined cardiovascular outcomes was higher in the metformin-insulin group (40.


    In conclusion, comparative studies found that patients treated with metformin-sulfonylurea had a higher rate of target HbA1c levels and fewer


    References: 1.


    2.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.